25/11/2011

Report no. 113/2011

Amendment to a significant contract in the subsidiary company “Powiatowe Centrum Zdrowia” sp. z o.o. in Kowary

Pursuant to §5 (1) (3) of the Regulation of the Minister of Finances of 19 February 2009 on current and periodical information provided by issuers of securities, the Management Board of EMC Instytut Medyczny S.A. informs that on 25 November 2011 the Company received annexes to the contracts concluded by the subsidiary company Powiatowe Centrum Zdrowia sp. z o.o. with the National Health Fund - the Dolnośląskie Voivodeship Branch in Wrocław (the Fund Branch) regarding healthcare services in the scope of outpatient specialist care,  outpatient specialist care (in terms of comprehensive outpatient specialist care of patients with chronic disease - KAOS) for the period from 1 January to 31 December 2011.

Healthcare services referred to hereinabove are provided by the subsidiary company of EMC Instytut Medyczny S. A .“Powiatowe Centrum Zdrowia” sp. z o.o. in Kowary.

The Issuer informed about the contracts concluded by “Powiatowe Centrum Zdrowia” sp. z o.o. in Kowary with the Fund Branch concerning rendering services in 2011 in its current reports nos.: 17/2011 of 25.01.2011, 23/2011 of 01.02.2011, 26/2011 of 04.02.2011, 34/2011 of 03.03.2011, 40/2011 of 14.03.2011, 59/2011 of 05.04.2011, 63/2011 of 06.05.2011, 66/2011 of 23.05.2011, 71/2011 of 16.06.2011, 78/2011 of 05.07.2011, 82/2011 of 11.07.2011, 84/2011 of 15.07.2011, 92/2011 of 05.08.2011, 94/2011 of 18.08.2011 and 106/2011 of 02.11.2011

As a result of signing the said annexes, the total maximum Fund Branch liability towards the subsidiary company Powiatowe Centrum Zdrowia sp. z o.o. in  Kowary has changed and it  currently amounts to PLN 15,704,225.74  (an increase by PLN 11,021.74) for the period from 1 January to 31 December 2011.

The other material terms of the contract with the highest value made public remain unchanged.
A criterion for a contract to be considered significant:
The value of contracts exceeds 10% of the Issuer’s equity capital.